Reports Summarize Chronic Myeloid Leukemia Research from Chinese University of Hong Kong (PBA2, a novel inhibitor of the b-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation)

Source :: Obesity, Fitness & Wellness Week. October 19, 2024, 3849
Publication Year :: 2024
Abstract: 2024 OCT 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on chronic myeloid leukemia have been published. According to [...]

Subjects :: Chinese University of Hong Kong
Care and treatment
Genetic aspects
Prognosis
Physical fitness
Cancer research -- Genetic aspects
Tyrosine -- Genetic aspects
Chronic myeloid leukemia -- Genetic aspects -- Prognosis -- Care and treatment
Oncology, Experimental -- Genetic aspects
Cancer -- Research

Tools